Dallas, TX, United States of America

Qinglan Ling

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qinglan Ling. Retrieved from https://idiyas.com/inventor/qinglan-ling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qinglan Ling - Innovator in Gene Delivery Technologies

Introduction

Qinglan Ling is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of gene therapy, particularly through his innovative work on adeno-associated viral vectors.

Latest Patents

Qinglan Ling holds a patent for a recombinant adeno-associated viral vector for gene delivery. This patent addresses methods and compositions for treating diseases and genetic disorders linked to SURF1 loss and/or malfunction. The disclosed methods involve rAAV vectors and rAAV viral vectors that comprise transgene nucleic acid molecules encoding for a SURF1 polypeptide. He has 1 patent to his name.

Career Highlights

Qinglan Ling is affiliated with the University of Texas System, where he continues to advance research in gene delivery technologies. His work has the potential to impact the treatment of various genetic disorders.

Collaborations

One of his notable collaborators is Steven J Gray, with whom he has worked on various projects related to gene therapy and vector development.

Conclusion

Qinglan Ling's contributions to gene delivery technologies highlight his role as an innovator in the field. His work promises to enhance the understanding and treatment of genetic disorders, making a significant impact on medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…